当前位置: 首页 > 详情页

Transforming growth factor-beta 1 promotes breast cancer metastasis by downregulating miR-196a-3p expression

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China [2]Department of Pathology, School of Biology ﹠ Basic Medical Sciences, Soochow University, Suzhou 215123, China [3]Department of Surgery, The People’s Hospital of Sihong County, Sihong 223900, Jiangsu Province, China [4]Laboratory Animal Research Center, Soochow University School of Medicine, Suzhou 215123, China [5]Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China [6]Laboratory of Molecular Pathology, Soochow University & Sihong County People’s Hospital, Suzhou 215123, China [7]Suzhou Key Laboratory of Tumor Microenvironment and Pathology, Soochow University, Suzhou 215006, China
出处:
ISSN:

关键词: microRNA miR-196a-3p transforming growth factor-beta 1 breast cancer

摘要:
Transforming growth factor-beta 1 is considered a key contributor to the progression of breast cancer. MicroRNAs are important factors in the development and progression of many malignancies. In the present study, upon studies of breast cancer cell lines and tissues, we showed that microRNA -196a-3p is decreased by transforming growth factor-beta 1 in breast cancer cells and associated with breast cancer progression. We identified neuropilin-2 as a target gene of microRNA -196a-3p and showed that it is regulated by transforming growth factor-beta 1. Moreover, transforming growth factor-beta 1-mediated inhibition of microRNA -196a-3p and activation of neuropilin-2were required for transforming growth factor-beta 1-induced migration and invasion of breast cancer cells. In addition, neuropilin-2 expression was suppressed in breast tumors, particularly in triple-negative breast cancers. Collectively, our findings strongly indicate that microRNA -196a-3p is a predictive biomarker of breast cancer metastasis and patient survival and a potential therapeutic target in metastatic breast cancer.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 1 区 医学
小类 | 2 区 细胞生物学 2 区 肿瘤学
最新[2025]版:
JCR分区:
出版当年[2015]版:
Q1 CELL BIOLOGY Q1 ONCOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Department of Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China [2]Department of Pathology, School of Biology ﹠ Basic Medical Sciences, Soochow University, Suzhou 215123, China
共同第一作者:
通讯作者:
通讯机构: [2]Department of Pathology, School of Biology ﹠ Basic Medical Sciences, Soochow University, Suzhou 215123, China [6]Laboratory of Molecular Pathology, Soochow University & Sihong County People’s Hospital, Suzhou 215123, China [7]Suzhou Key Laboratory of Tumor Microenvironment and Pathology, Soochow University, Suzhou 215006, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16996 今日访问量:0 总访问量:905 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院